Outcome of ventilator-associated pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa treated with aerosolized colistin in neonates: A retrospective chart review

European Journal of Pediatrics

Volumn 171, Issue 2, 2012, Pages 311-316

  Celik, Istemi Han ^a   Oguz, Serife Suna ^a   Demirel, Gamze ^a   Erdeve, Omer ^a   Dilmen, Ugur ^a  

^a Zekai Tahir Burak Maternity Teaching Hospital   (Turkey)

Author keywords

Acinetobacter baumannii; Aerosolized colistin; Multidrug resistant gram negative bacilli; Newborn; Pseudomonas aeruginosa; Ventilator associated pneumonia

Indexed keywords

AMIKACIN; CIPROFLOXACIN; COLISTIN; MEROPENEM; MESYLIC ACID; SODIUM;

ACINETOBACTER BAUMANNII; ADULT; AEROSOL; ANTIMICROBIAL THERAPY; BACTERIUM ISOLATION; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; MULTIDRUG RESISTANCE; NEPHROTOXICITY; PREMATURITY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW; VENTILATOR ASSOCIATED PNEUMONIA;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADMINISTRATION, INHALATION; ANTI-BACTERIAL AGENTS; COLISTIN; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; MALE; PNEUMONIA, VENTILATOR-ASSOCIATED; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84857053317     PISSN: 03406199     EISSN: 14321076     Source Type: Journal    
DOI: 10.1007/s00431-011-1537-z     Document Type: Review

References (45)

1. RD Baines Jr D Rifkind 1964 Intravenous administration of sodium colistimethate JAMA 190 278 281 14197982 10.1001/jama.1964.03070170019004
2. P Beringer 2001 The clinical use of colistin in patients with cystic fibrosis Curr Opin Pulm Med 7 434 440 11706322 1:STN:280:DC%2BD3MnltlSruw%3D%3D 10.1097/00063198-200111000-00013 (Pubitemid 33065550)
3. HW Boucher GH Talbot JS Bradley JE Edwards D Gilbert LB Rice M Scheld B Spellberg J Bartlett 2009 Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America Clin Infect Dis 48 1 12 19035777 10.1086/595011
4. L Cordero M Sananes P Dedhiya LW Ayers 2001 Purulence and gram-negative bacilli in tracheal aspirates of mechanically ventilated very low birth weight infants J Perinatol 21 376 381 11593372 1:STN:280:DC%2BD3MrksFajtQ%3D%3D 10.1038/sj.jp.7210549 (Pubitemid 32851267)
5. L Cordero LW Ayers RR Miller JH Seguin BD Coley 2002 Surveillance of ventilator-associated pneumoniae in very-low-birth-weight infants Am J Infect Control 30 32 39 11852414 10.1067/mic.2002.119995 (Pubitemid 34155280)
6. S Cunningham A Prasad L Collyer S Carr IB Lynn C Wallis 2001 Bronchoconstriction following nebulised colistin in cystic fibrosis Arch Dis Child 84 432 433 11316693 1:STN:280:DC%2BD3MzgvV2guw%3D%3D 10.1136/adc.84.5.432 (Pubitemid 32411237)
7. ME Falagas SK Kasiakou 2005 Colistin: the reviwal of polymyxins for the management of multidrug-resistant gram-negative bacterial infections Clin Infect Dis 40 1333 1341 15825037 1:CAS:528:DC%2BD2MXktlajsro%3D 10.1086/429323 (Pubitemid 40570245)
8. ME Falagas SK Kasiakou 2006 Toxicity of polymyxins: a systematic review of the evidence from old and recent studies Crit Care 10 R27 16507149 10.1186/cc3995 (Pubitemid 47079794)
9. ME Falagas SK Kasiakou S Tsiodras A Michalopoulos 2006 The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature Clin Med Res 4 138 146 16809407 1:CAS:528:DC%2BD28XotFeju7k%3D 10.3121/cmr.4.2.138 (Pubitemid 44047368)
10. ME Falagas G Sideri EK Vouloumanou JH Papadatos DA Kafetzis 2009 Intravenous colistimethate (colistin) use in critically ill children without cystic fibrosis Pediatr Infect Dis J 28 123 127 19116601 10.1097/INF. 0b013e31818a5dbd
11. ME Falagas II Siempos PI Rafailidis IP Korbila E Ioannidou A Michalopoulos 2009 Inhaled colistin as monotherapy for multidrug-resistant gram (-) nosocomial pneumoniae: a case series Respir Med 103 707 713 19118994 10.1016/j.rmed.2008.11.018
12. ME Falagas EK Vouloumanou PI Rafailidis 2009 Systemic colistin use in children without cystic fibrosis: a systematic review of the literature Int J Antimicrob Agents 33 503 e1 503 e13 10.1016/j.ijantimicag.2008.10.021
13. ME Falagas G Sideri IP Korbila EK Vouloumanou JH Papadatos DA Kafetzis 2010 Inhaled colistin for the treatment of tracheobronchitis and pneumoniae in critically ill children without cystic fibrosis Pediatr Pulmonol 45 1135 1140 20658485 10.1002/ppul.21302
14. FR Fekety Jr PS Norman LE Cluff 1962 The treatment of gram-negative bacillary infections with colistin. The toxicity and efficacy of large doses in forty-eight patients Ann Intern Med 57 214 229 13892094
15. JS Garland 2010 Strategies to prevent ventilator-associated pneumoniae in neonates Clin Perinatol 37 629 643 20813275 10.1016/j.clp.2010.05.003
16. JS Garner WR Jarvis TG Emori TC Horan JM Hughes 1988 CDC definitions for nosocomial infections, 1988 Am J Infect Control 16 128 140 2841893 1:STN:280:DyaL1czgvVSnug%3D%3D 10.1016/0196-6553(88)90053-3
17. GN Gold AP Richardson Jr 1966 An unusual case of neuromuscular blockade seen with therapeutic blood levels of colistin methanesulfonate (Coly-Mycin) Am J Med 41 316 321 5912305 1:STN:280:DyaF2s%2FgtlWltA%3D%3D 10.1016/0002-9343(66) 90026-X
18. JB Gouyon JP Guignard 2000 Management of acute renal failure in newborns Pediatr Nephrol 14 1037 1044 10975322 1:STN:280:DC%2BD3M%2FltVGjtA%3D%3D 10.1007/s004670050068 (Pubitemid 30621323)
19. J Goverman JM Weber TJ Keaney RL Sheridan 2007 Intravenous colistin for the treatment of multi-drug resistant, gram-negative infection in the pediatric burn population J Burn Care Res 28 421 426 17438490 10.1097/BCR.0B013E318053D346 (Pubitemid 46733249)
20. DH Hamer 2000 Treatment of nosocomial pneumoniae and tracheobronchitis caused by multidrug-resistant Pseudomonas aeruginosa with aerosolized colistin Am J Respir Crit Care Med 162 328 330 10903263 1:STN:280:DC%2BD3cvisFCjuw%3D%3D (Pubitemid 30469842)
21. ME Hodson CG Gallagher JR Govan 2002 A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis Eur Respir J 20 658 664 12358344 1:CAS:528:DC%2BD38Xotl2is7c%3D 10.1183/09031936.02.00248102
22. R Imberti M Cusato P Villani L Carnevale GA Iotti M Langer M Regazzi 2010 Steady-state pharmacokinetics and BAL concentration of colistin in critically Ill patients after IV colistin methanesulfonate administration Chest 138 1333 1339 20558557 1:CAS:528:DC%2BC3MXks1ajsA%3D%3D 10.1378/chest.10-0463
23. E Iosifidis C Antachopoulos M Ioannidou M Mitroudi M Sdougka V Drossou-Agakidou M Tsivitanidou E Roilides 2010 Colistin administration to pediatric and neonatal patients Eur J Pediatr 169 867 874 20119725 1:CAS:528:DC%2BC3cXmsFWgsr8%3D 10.1007/s00431-009-1137-3
24. R Isturiz 2008 Global resistance trends and the potential impact on empirical therapy Int J Antimicrob Agents 32 Suppl 4 S201 S206 19134520 1:CAS:528:DC%2BD1MXmtV2qsg%3D%3D 10.1016/S0924-8579(09)70003-2
25. SK Kasiakou A Michalopoulos ES Soteriades G Samonis GJ Sermaides ME Falagas 2005 Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis Antimicrob Agents Chemother 49 3136 3146 16048915 1:CAS:528:DC%2BD2MXntFCht78%3D 10.1128/AAC.49.8.3136-3146.2005 (Pubitemid 41060551)
26. J Koch-Weser VW Sidel EB Federman P Kanarek DC Finer AE Eaton 1970 Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy Ann Intern Med 72 857 868 5448745 1:STN:280:DyaE3c3lslKnsQ%3D%3D
27. YKA Koyama A Tsuchiya A Takayata 1950 A new antibiotic "colistin" produced by spore-forming soid bacteria J Antibiot (Tokyo) 3 457 458
28. AL Kwa C Loh JG Low A Kurup VH Tam 2005 Nebulized colistin in the treatment of pneumoniae due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa Clin Infect Dis 41 754 757 16080101 10.1086/432583 (Pubitemid 41170367)
29. AS Levin AA Barone J Penco MV Santos IS Marinho EA Arruda EI Manrique SF Costa 1999 Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii Clin Infect Dis 28 1008 1011 10452626 1:CAS:528:DyaK1MXjtVOhs7Y%3D 10.1086/514732 (Pubitemid 29203530)
30. CC Lin TC Liu CF Kuo CP Liu CM Lee 2010 Aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii pneumonia: experience in a tertiary care hospital in northern Taiwan J Microbiol Immunol Infect 43 323 331 20688293 1:CAS:528:DC%2BC3cXhtFKktb%2FL 10.1016/S1684-1182(10)60050-3
31. LA Lindesmith RD Baines Jr DB Bigelow TL Petty 1968 Reversible respiratory paralysis associated with polymyxin therapy Ann Intern Med 68 318 327 4306125 1:STN:280:DyaF1M7ptVGrsQ%3D%3D
32. Q Lu C Girardi M Zhang B Bouhemad K Louchahi O Petitjean F Wallet MH Becquemin G Le Naour CH Marquette JJ Rouby 2010 Nebulized and intravenous colistin in experimental pneumoniae caused by Pseudomonas aeruginosa Intensive Care Med 36 1147 1155 20397007 1:CAS:528:DC%2BC3cXntVCku7g%3D 10.1007/s00134-010-1879-4
33. N Markou H Apostolakos C Koumoudiou M Athanasiou A Koutsoukou I Alamanos L Gregorakos 2003 Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients Crit Care 7 R78 R83 12974973 10.1186/cc2358
34. AS Michalopoulos S Tsiodras K Rellos S Mentzelopoulos ME Falagas 2005 Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic Clin Microbiol Infect 11 115 121 15679485 1:CAS:528:DC%2BD2MXit1amtbo%3D 10.1111/j.1469-0691.2004.01043.x (Pubitemid 40259694)
35. N Nakwan J Wannaro T Thongmak P Pornladnum R Saksawad K Chokephaibulkit 2011 Safety in treatment of ventilator-associated pneumoniae due to extensive drug-resistant Acinetobacter baumannii with aerosolized colistin in neonates: a preliminary report Pediatr Pulmonol 46 60 66 20812247 10.1002/ppul.21324
36. RL Perkins 1964 Apnea with intramuscular colistin therapy JAMA 190 421 424 14197992 1:STN:280:DyaF2M%2Fgt1eltw%3D%3D 10.1001/jama.1964.03070180019004
37. F Ratjen E Rietschel D Kasel R Schwiertz K Starke H Beier S van Koningsbruggen H Grasemann 2006 Pharmacokinetics of inhaled colistin in patients with cystic fibrosis J Antimicrob Chemother 57 306 311 16396919 1:CAS:528:DC%2BD28XovVGmsg%3D%3D 10.1093/jac/dki461 (Pubitemid 43160174)
38. M Schina E Spyridi M Daoudakis E Mertzanos S Korfias 2006 Successful treatment of multidrug-resistant Pseudomonas aeruginosa meningitis with intravenous and intrathecal colistin Int J Infect Dis 10 178 179 16263315 10.1016/j.ijid.2005.03.005 (Pubitemid 43255606)
39. Services DoHaH (March, 2009) Ventilator-associated pneumoniae (VAP) event
40. Souli M, Galani I, Giamarellou H (2008) Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe. Euro Surveill 13(47)
41. LG Tallgren K Liewendahl B Kuhlbaeck 1965 The therapeutic success and nephrotoxicity of colistin in acute and chronic nephropathies with Impaired renal function Acta Med Scand 177 717 728 14334665 1:STN:280: DyaF2M7jvFenuw%3D%3D 10.1111/j.0954-6820.1965.tb01882.x
42. C Urban S Segal-Maurer JJ Rahal 2003 Considerations in control and treatment of nosocomial infections due to multidrug-resistant Acinetobacter baumannii Clin Infect Dis 36 1268 1274 12746772 1:CAS:528:DC%2BD3sXltVKjsbs%3D 10.1086/374847 (Pubitemid 36629937)
43. TM Yuan LH Chen HM Yu 2007 Risk factors and outcomes for ventilator-associated pneumoniae in neonatal intensive care unit patients J Perinat Med 35 334 338 17547540 10.1515/JPM.2007.065 (Pubitemid 47036966)
44. AP Zavascki LZ Goldani J Li RL Nation 2007 Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review J Antimicrob Chemother 60 1206 1215 17878146 1:CAS:528:DC%2BD2sXhtlKmt7fP 10.1093/jac/dkm357 (Pubitemid 350168315)
45. G Ziv JF Nouws CA van Ginneken 1982 The pharmacokinetics and tissue levels of polymyxin B, colistin and gentamicin in calves J Vet Pharmacol Ther 5 45 58 6284955 1:CAS:528:DyaL38XktFKltrY%3D 10.1111/j.1365-2885.1982.tb00497.x